Abeona Therapeutics
ABEO
43 hedge funds and large institutions have $30.1M invested in Abeona Therapeutics in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 8 closing their positions.
511% more call options, than puts
Call options by funds: $171K | Put options by funds: $28K
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
41% more capital invested
Capital invested by funds: $21.3M → $30.1M (+$8.79M)
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
2% more funds holding
Funds holding: 42 → 43 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$6.86M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.19M |
| 3 |
SFM
Soros Fund Management
New York
|
+$2.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$965K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$445K |
| 2 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$247K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$239K |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$108K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$102K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| – | -$664 | -5 | Closed |
|
ABEO Hedge Fund Activity: Q3 2015 in Review
43 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2015, worth a combined $30.1M — up 41% from $21.3M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ABEO positions and 8 closed out — a net gain of 1 holder — while 16 added to existing stakes and 8 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $6.86M. The largest seller was Morgan Stanley, cutting an estimated $445K.
- 43 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2015, up from 42 in Q2 2015.
- Funds reported $30.1M of Abeona Therapeutics stock for Q3 2015, up 41% quarter-over-quarter.
- 9 funds opened new Abeona Therapeutics positions in Q3 2015 and 8 closed out, a net change of +1 holder.
- The largest Abeona Therapeutics buyer in Q3 2015 was Perceptive Advisors, an estimated $6.86M added.
- The largest Abeona Therapeutics seller in Q3 2015 was Morgan Stanley, an estimated $445K sold.
Based on aggregated 13F filings for Q3 2015.